Chi-Med has issued a total of 666,577,450 ordinary shares. Each Nasdaq-listed American Depositary Share (ADS) equates to five ordinary shares.
For illustrative purposes only, if converted in their entirety, this would be equivalent to 133,315,490 Nasdaq-traded ADSs.
Insofar as Chi-Med is aware, approximately 63% of the issued share capital of Chi-Med is not in public hands. Such percentage comprises the shares held by Directors and Hutchison Healthcare Holdings Limited, a significant shareholder of Chi-Med.
The tables below show major interests in shares of the Company, notified to the Company under the provisions of rule 5 of the Disclosure Rules and Transparency Rules of the U.K. Financial Conduct Authority, which have been incorporated by reference into the Company's Articles of Association.
Last updated: May 30, 2019
| Shareholder | Number of Ordinary Shares held | Number of American Depositary Shares Held | Approximate % of Issued Share Capital |
|---|---|---|---|
| Hutchison Healthcare Holdings Limited | 366,666,670 | 6,862,420 | 60.15% |
| Mitsui & Co., Ltd. | 16,144,040 | 1,837,692 | 3.80% |
| Director | Number of Ordinary Shares held | Number of American Depositary Shares Held | Approximate % of Issued Share Capital |
|---|---|---|---|
| Christian Hogg | 10,938,020 | 53,060 | 1.68% |
| Johnny Cheng | 2,561,460 | 8,544 | 0.39% |
| Simon To | 1,800,000 | 133,237 | 0.37% |
| Edith Shih | 700,000 | 100,000 | 0.18% |
| Weiguo Su | 61,186 | 0.05% | |
| Dan Eldar | 19,000 | 8,993 | 0.01% |
| Tony Mok | 10,002 | 0.008% | |
| Paul Carter | 35,240 | 0.005% | |
| Karen Ferrante | 5,785 | 0.004% | |
| Graeme Jack | 3,000 | 0.002% | |
Note: "Held" means any legal or beneficial interest held, whether directly or indirectly, on the account of the Director and such Director's "persons closely associated" (as defined in article 3 of the EU Market Abuse Regulation (No 596/2014)).